Cardiovascular disease (CVD) is all around us. Whether you’ve been warned by a healthcare provider that your LDL levels are too high, or a loved one has experienced a heart attack or stroke, many of us have been touched in some way by the disease. As the leading cause of death in the United States, cardiovascular disease is one of the few diseases that transcends gender, geographic, racial, and ethnic lines1. It is also responsible for an exorbitant portion of healthcare expenditure in this country—equating to $219 billion spent per year in health care services, medications, and premature deaths2.
While health care providers are aware of the importance of managing cholesterol levels as a way of improving health outcomes, boosting quality of life, and containing costs, this work can often feel like an uphill battle. Mitigating cardiovascular disease requires a well-coordinated, systematic approach that involves screening for dyslipidemia, intensifying medication to prevent clinical inertia, and taking a population health approach to ensure individuals are engaged and treated equitably.
Mitigating cardiovascular disease requires a well-coordinated, systematic approach that involves screening for dyslipidemia, intensifying medication to prevent clinical inertia, and taking a population health approach to ensure individuals are engaged and treated equitably.
To support practices in putting systems in place to care for patients more efficiently and effectively, Million Hearts/NACHC/AMA created the Cholesterol Management Change Package. This change package provides organizations with best practices that outpatient clinical settings can implement to achieve higher rates of cholesterol management within their communities. The change package features several evidence-based tools and resources, suggested by experts in the field, that can support practices in achieving cholesterol management through a multi-pronged approach. These tools include Azara DRVS functionality to drive patient, performance, and population health management.
Check out the Million Hearts Cholesterol Management Change Package to explore how DRVS can help your practice identify patients “hiding in plain sight”; manage comorbidities with ASCVD, hyperlipidemia, and diabetes; evaluate statin prescribing practices; and assess the equitability of care delivery and health outcomes.
If your practice is implementing evidence-based, innovative solutions to improving cholesterol management, we are eager to learn about your efforts. Are you leveraging the ASCVD Risk Registry to identify patients at high risk for ASCVD? Are you using alerts on the PVP to identify patients who could benefit from a statin prescription? If you have a success story you’d like to share with us, we’d love to hear from you.
Want to learn more? Join us this Thursday, June 27th at 2:00 PM ET for our webinar, Advancing ASCVD Care Through Cholesterol Management, to learn more about the Change Package and the evidence-based practices you can implement to support CVD care at your practice.
[1] https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html#:~:text=In%20the%20United%20States%3A,33%20seconds%20from%20cardiovascular%20disease.
[2]https://www.cdc.gov/policy/polaris/healthtopics/heartdisease/index.html#:~:text=Heart%20disease%20costs%20the%20United,%2C%20medications%2C%20and%20premature%20death